2SLGBTQIA+ Patient & Public Advisory Team for Equity, Diversity & Inclusion in Organ Donation and Transplantation in Canada

Study Lead

Dr. Murdoch Leeies

University of Manitoba

Overview

Dr. Murdoch Leeies‘ team at University of Manitoba is forming a 2SLGBTQIA+ patient/family advisory team and is looking for interested people who have been involved with the organ donation or transplantation system. If you are a 2SLGBTQIA+ identifying person who has been a living organ donor, a solid organ transplant recipient or the substitute-decision maker or caregiver of a 2SLGBTQIA+ person who was considered for donation after death (whether they did or did not donate) then they hope you will consider registering your interest to participate.

The team hopes that your engagement will help them to design research as well as policies that can improve equity for 2SLGBTQIA+ people in our health system. We greatly value your participation.

Type of Participation

Patient Partnership

Treatment

Transplantation

Location

All provinces and territories

Related studies

  • Promoting shared decision making for people with advanced chronic kidney disease

    Overview:

    Study type: Focus Group

    August 8, 2024

  • Improving the Care and Experiences of Living Kidney Donors

    Overview: Seeking family physicians and transplant healthcare professionals for an online interview that will help develop tools to improve the experiences, care, and outcomes of living kidney donors.

    Study type: Interview

    July 25, 2024

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024